POMC and Parkinson disease: Volpi et al. compared the incremental response of ACTH and cortisol to administration of CRH and the non-specific serotonin receptor agonist fenfluramine in 10 PD patients who did not differ in basal ACTH/cortisol levels compared to controls (287).